Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07356492 · ClinicalTrials.gov registry record · NA

Expanding Veteran Sponsorship Initiative+ to Support High-Risk Transitioning Servicemembers and Veterans: A Precision Medicine Approach

A NA study of Health and Connectedness, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
2,700
Enrollment target
1
Study location

NCT07356492 is a NA study of Health and Connectedness that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 2,700 participants, roughly in line with the 2,837-participant average among 6 other Health trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07356492, a NA study of Health and Connectedness, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
2,700 participants
Enrollment target
1
Study location

Study Summary

Background Young Veterans in the U.S. face a heightened risk of suicide, particularly during the first year after leaving military service-a period often referred to as the "deadly gap." Suicide rates among Veterans aged 18 to 34 have nearly doubled since 2001, and research shows that reintegration challenges during this transition are closely linked to increased suicide risk. The Veteran Sponsorship Initiative (VSI) was developed to address this critical period by connecting Transitioning Servicemembers and Veterans (TSMVs) with trained, VA-certified peer sponsors. These sponsors help TSMVs navigate civilian life and access VA care. Early evaluations show that TSMVs matched with sponsors are more likely to report lower levels of reintegration difficulties, higher levels of social support, engage in VA services and report lower rates of depression and suicide risk. This project enhances VSI by integrating predictive analytics-developed in partnership with Harvard Medical School and the DoW STARRS-LS team-to identify high-risk TSMVs before they leave the military. Those identified receive not only a sponsor but also targeted VA mental and health care services. This hybrid effectiveness-implementation study will evaluate the impact of this enhanced model (VSI+) on mental health outcomes and VA engagement among 2,700 high-risk TSMVs. Method/Design The purpose of this PEI proposal is to evaluate VSI expansion into VSI+ with enrollment occurring on four US Army installations (FY2026-2027). The study employs a pragmatic cluster-randomized trial with embedded mixed-method implementation evaluation to compare three arms: 1. Transition as Usual (TAU) 2. VSI Base= peer sponsorship and community support 3. VSI+= VSI Base plus VA stepped care services The evaluation is guided by the RE-AIM framework to assess: * Reach (enrollment rates) * Effectiveness (reintegration difficulties, depression, anxiety, suicidal ideation/behavior, and VA utilization outcomes) * Adoption (s

Interventions

  • BEHAVIORAL Onward Ops- receive peer sponsor and community support
  • BEHAVIORAL VA stepped care services

Study Locations (1)

New York

  • James J. Peters VA Medical Center, Bronx, NY - The Bronx

Trial Details

FieldValue
Enrollment Target 2,700 participants
Start Date 2026-01-01
Est. Completion 2027-09-30
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT07356492

The ClinicalTrials.gov registry entry for NCT07356492 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 2,700 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 2,837-participant average among 6 other Health trials with a reported enrollment target. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Health appearing as the primary indexed condition, and to 2 interventions - of which Onward Ops- receive peer sponsor and community support is the first listed.

NCT07356492 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT07356492 about?

NCT07356492 is a clinical study titled "Expanding Veteran Sponsorship Initiative+ to Support High-Risk Transitioning Servicemembers and Veterans: A Precision Medicine Approach". Background Young Veterans in the U.S. face a heightened risk of suicide, particularly during the first year after leaving military service-a period often referred to as the "deadly gap." Suicide rates among Veterans aged 18 to 34 have nearly doubled since 2001, and research shows that reintegration ...

What is the current status of trial NCT07356492?

This trial is currently recruiting. It is a NA study. The enrollment target is 2,700 participants. The study started on 2026-01-01. Estimated completion is 2027-09-30.

What conditions does trial NCT07356492 study?

This clinical trial studies the following conditions: Health, Connectedness, Reintegration Difficulties, Suicidal Ideation and Behaviors.

What interventions are being tested in trial NCT07356492?

The interventions under investigation include: Onward Ops- receive peer sponsor and community support (BEHAVIORAL), VA stepped care services (BEHAVIORAL).

Who is sponsoring clinical trial NCT07356492?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07356492 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Health

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.